ATE800T1 - Als herzstimulantien wirksame phthalazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents

Als herzstimulantien wirksame phthalazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE800T1
ATE800T1 AT80300909T AT80300909T ATE800T1 AT E800 T1 ATE800 T1 AT E800T1 AT 80300909 T AT80300909 T AT 80300909T AT 80300909 T AT80300909 T AT 80300909T AT E800 T1 ATE800 T1 AT E800T1
Authority
AT
Austria
Prior art keywords
phthalazines
preparation
pharmaceutical compositions
compositions containing
active cardiac
Prior art date
Application number
AT80300909T
Other languages
English (en)
Inventor
Simon Fraser Campbell
John Christopher Danilewicz
Allan Leslie Ham
John Kendrick Stubbs
Original Assignee
Pfizer Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corporation filed Critical Pfizer Corporation
Application granted granted Critical
Publication of ATE800T1 publication Critical patent/ATE800T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT80300909T 1979-03-28 1980-03-24 Als herzstimulantien wirksame phthalazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. ATE800T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7910843 1979-03-28
EP80300909A EP0017411B1 (de) 1979-03-28 1980-03-24 Als Herzstimulantien wirksame Phthalazine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE800T1 true ATE800T1 (de) 1982-04-15

Family

ID=10504188

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80300909T ATE800T1 (de) 1979-03-28 1980-03-24 Als herzstimulantien wirksame phthalazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Country Status (13)

Country Link
EP (1) EP0017411B1 (de)
JP (1) JPS55130973A (de)
AR (2) AR224518A1 (de)
AT (1) ATE800T1 (de)
AU (1) AU518701B2 (de)
DE (1) DE3060253D1 (de)
DK (1) DK129380A (de)
ES (2) ES489947A0 (de)
FI (1) FI800938A7 (de)
GR (1) GR67739B (de)
IL (1) IL59619A0 (de)
PH (1) PH15981A (de)
PT (1) PT71025A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
CA2262569A1 (en) 1996-08-09 1998-02-19 Norihito Ohi Benzopiperidine derivatives
WO2012006276A1 (en) * 2010-07-06 2012-01-12 North Carolina State University Inhibition of bacterial biofilms with aryl carbamates
US9125408B2 (en) 2010-09-01 2015-09-08 North Carolina State University Use of aryl carbamates in agriculture and other plant-related areas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148482B (de) * 1977-06-03 1981-03-07 Pfizer
GB2008104B (en) * 1977-11-03 1982-03-10 Pfizer Ltd Therapeutic agents
GB2007654B (en) * 1977-11-03 1982-06-16 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
AU518701B2 (en) 1981-10-15
AR224518A1 (es) 1981-12-15
JPS5716111B2 (de) 1982-04-02
JPS55130973A (en) 1980-10-11
GR67739B (de) 1981-09-16
ES8104273A1 (es) 1981-04-16
AR223434A1 (es) 1981-08-14
ES497172A0 (es) 1981-10-16
ES489947A0 (es) 1981-04-16
FI800938A7 (fi) 1981-01-01
PH15981A (en) 1983-05-16
DE3060253D1 (en) 1982-05-06
DK129380A (da) 1980-09-29
ES8200103A1 (es) 1981-10-16
EP0017411B1 (de) 1982-03-31
EP0017411A1 (de) 1980-10-15
PT71025A (en) 1980-04-01
IL59619A0 (en) 1980-06-30
AU5691780A (en) 1980-10-02

Similar Documents

Publication Publication Date Title
ATE6934T1 (de) Sulfonylharnstoffe, verfahren zu ihrer herstellung und pharmazeutische praeparate enthaltend diese verbindungen.
ATE17725T1 (de) Gegen entzuendung wirksame 5-substituierte 2,3diaryl-thiophene, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE6859T1 (de) Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE8892T1 (de) Substituierte azabicyclooctancarboxylsaeure, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE4707T1 (de) Pyridyl- und imidazopyridyloxypropanolamine, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen sie enthaltend.
ATE27451T1 (de) Acyl-chinolinonderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung.
PT68492A (de) Fluorsubstituierte phenoxybenzyloxycarbonylderivate verfahren zu ihrer herstellung und ihre verwendeung als insektizide und akarizide
PT66858A (de) 2-benzylpyrrolidine,verfahren zu ihrer herstellung und sie enthaltende arzneimittel
PT71967A (de) Homoserin-derivate verfahren zu ihrer herstellung und ihreverwendung als mikrobizide
PT74129B (de) 3,4-bis-substituierte 1,2,5-oxdiazol-2-oxide verfahren zu ihrer herstellung ihre verwendung und sie enthaltende pharmazeutische zubereitungen
ATE800T1 (de) Als herzstimulantien wirksame phthalazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE3422T1 (de) Tetrahydrochinolinderivate, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen.
ATE2673T1 (de) Phenothiazinderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.
ATE3425T1 (de) Hypoglykaemische guanylamidine, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE3976T1 (de) Substituierte 3-(1-pyrrolidinyl)-5-sulfamoylbenzoes[ure-derivate, verfahren zu ihrer herstellung, pharmazeutische zubereitungen, die sie enthalten und verfahren zu deren herstellung.
ATE6653T1 (de) Clavulansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE12116T1 (de) 7-acylamino-3-substituierte cephalasporansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE1014T1 (de) Substituierte-19-nor-preg n-4-en-3,20-dion-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE876T1 (de) Anti-inflammatorische 4,5 -diaryl-2-nitroimidazole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzung.
ATE7394T1 (de) 1,2,4-triazinylthiomethyl-3-cephem-sulfoxyde, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE11288T1 (de) Thioalkylamid des nicotinsaeure-1-oxids, seine salze, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen.
ATE587T1 (de) Indolalkylamine, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.
ATE21515T1 (de) 7-n-heterocyclyl-cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzung.
ATE6503T1 (de) Carboxyalkyl-dipeptid-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzung.
ATE6515T1 (de) Tetrahydroisochinolin-derivate, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee